Important Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with your healthcare provider before making any changes to your medication regimen. The information provided is based on general guidelines and may not apply to your specific situation.

Emergency Warning

If you are experiencing severe withdrawal symptoms or mental health concerns after stopping GLP-1 medications, seek immediate medical attention. Do not attempt to manage severe symptoms on your own.

Introduction

GLP-1 medications, including Ozempic, Wegovy, Mounjaro, and others, have become increasingly popular for weight management and diabetes control. However, some individuals may need to stop these medications abruptly due to side effects or other reasons. This article explores the risks and potential consequences of quitting GLP-1 medications cold turkey.

Common GLP-1 Medications

Here are the most commonly prescribed GLP-1 medications and their generic names:

Semaglutide

  • Ozempic (diabetes)
  • Wegovy (weight loss)
  • Rybelsus (oral)

Tirzepatide

  • Mounjaro (diabetes)
  • Zepbound (weight loss)

Liraglutide

  • Victoza (diabetes)
  • Saxenda (weight loss)

Other GLP-1 Agonists

  • Dulaglutide (Trulicity)
  • Exenatide (Byetta, Bydureon)
  • Lixisenatide (Adlyxin)

Potential Withdrawal Symptoms

Microdose Tools & Resources

Disclaimer: GLP1Microdose.com is independent and not affiliated with Novo Nordisk, Eli Lilly, or any pharmaceutical manufacturer. Microdosing protocols are not FDA-approved dosing regimens. This article is educational only and does not constitute medical advice.